AVTX vs CPB · P/E 0.0, rev $441.0K vs P/E 12, rev $10.25B
Avalo Therapeutics Inc (AVTX) versus Campbell’s Co (CPB) — a side-by-side from cached financials, not a winner call.
Avalo Therapeutics Inc (AVTX) is a biotechnology company listed on US.
Campbell’s Co (CPB) is a packaged foods company listed on US.
Latest reported AVTX revenue for 2024-12-31 was $441.0K. Net income was -$35.1M. Revenue was down 77.1% from 2023-12-31 to 2024-12-31. AVTX currently screens at market cap $51.5M and trailing P/E 0.0.
Latest reported CPB revenue for 2025-08-03 was $10.25B. Net income was $602.0M. Revenue was up 6.4% from 2024-07-28 to 2025-08-03. CPB currently screens at market cap $6.46B and trailing P/E 11.8.
AVTX currently screens at market cap $51.5M and trailing P/E 0.0. CPB currently screens at market cap $6.46B and trailing P/E 11.8.
Not investment advice. Open the AVTX and CPB stock pages for the full models.
Not investment advice.